Topiramate
Product Images NDC 10544-628

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 10544-628). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure-topiramate (Image 01)

Chemical Structure-topiramate (Image 01)
Not-Available.*
FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
The text represents a graph showing the cumulative rates for time to the first seizure in individuals taking different doses of topiramate (50mg/day and 400mg/day). The graph displays time in days on the X-axis and the cumulative rate on the Y-axis. The data is shown using a line chart, with the results for the different doses represented by different lines.*
FDA Label Image

Label Graphic-25mg 90s (Image 03)

Label Graphic-25mg 90s (Image 03)
This is a description of a medication called Topiramate in tablet form, with a strength of 25 mg. The medication is available in a container with 90 tablets and is only available by prescription (Rx Only). The package insert recommends storing the medication at controlled room temperature. There is information about the manufacturer and lot numbers, but no information is available regarding usage or indications.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.